CorMedix (CRMD) Accumulated Expenses (2010 - 2025)

CorMedix (CRMD) has 15 years of Accumulated Expenses data on file, last reported at $16.9 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses rose 158.09% year-over-year to $16.9 million; the trailing twelve-month figure through Dec 2025 stood at $16.9 million (up 158.09% YoY), and the FY2025 full-year result was $16.9 million, up 158.09% from the prior year.
• Accumulated Expenses climbed to $16.9 million in Q4 2025, from $806506.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $16.9 million in Q4 2025 to a low of $806506.0 in Q3 2025.
• A 5-year average of $4.1 million and a median of $3.1 million in 2021 frame the typical range for Accumulated Expenses.
• Peak annual rise in Accumulated Expenses reached 158.09% in 2025, while the deepest fall reached 83.16% in 2025.
• Tracing CRMD's Accumulated Expenses over 5 years: stood at $3.0 million in 2021, then surged by 31.84% to $4.0 million in 2022, then tumbled by 31.59% to $2.7 million in 2023, then soared by 140.18% to $6.5 million in 2024, then soared by 158.09% to $16.9 million in 2025.
• Business Quant data shows CRMD's Accumulated Expenses at $16.9 million in Q4 2025, $806506.0 in Q3 2025, and $3.6 million in Q2 2025.